Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy

Files

Rovin, B.H.

Ronco, P.

Wetzels, J.F.M. Jack

Adler, S.G.

Ayoub, Isabelle

Zaoui, Philippe

Haertle, Stefan

Sprangers, B.